The Role of Diet and Supplements in Vitiligo Management




Vitiligo is an autoimmune disorder that involves the interplay between oxidative stress and the immune system. Preliminary observations suggest that the presence of gluten in the diet may play a role in vitiligo development in some patients, but to date vitiligo-specific diets have not been studied. The role of oral supplements, including vitamins, minerals, and botanicals, is increasingly being investigated as adjuncts to conventional medical treatment due to their antioxidant and immunomodulatory activity. Studies suggest that many of these agents may have some efficacy as monotherapy, but more often as adjuncts to topical agents and phototherapy.


Key points








  • Vitiligo is an autoimmune disorder that involves the interplay between oxidative stress and the immune system.



  • Preliminary observations suggest that the presence of gluten in the diet may play a role in vitiligo development in some patients, but to date vitiligo-specific diets have not been studied.



  • The role of oral supplements, including vitamins, minerals, and botanicals, is increasingly being investigated as adjuncts to conventional medical treatment due to their antioxidant and immunomodulatory activity.



  • Studies suggest that many of these agents may have some efficacy as monotherapy, but are more often as adjuncts to topical agents and phototherapy.






Introduction


Vitiligo is an acquired disorder of pigmentation characterized by well-defined depigmented patches of skin. Biopsies of lesional skin classically reveal an absence of epidermal melanocytes.


Multiple theories have been proffered for melanocyte destruction, including genetic, autoimmune, biochemical, viral, and melanocyte detachment mechanisms. Current research data suggest that autoimmune aberrations and oxidative stress are the key pathways mediating the destruction of melanocytes in vitiligo. Oxidative stress may initiate the cycle of destruction of melanocytes. An altered intracellular redox status and depletion of enzymatic and nonenzymatic antioxidants has been documented in the epidermis of patients with vitiligo. Hence, the generation of reactive oxygen species (ROS) may begin the cycle of destruction of melanocytes in genetically susceptible individuals by activation of the innate and adaptive immune response.


A variety of humoral and cell-mediated immune defects are reported in patients with vitiligo. However, multiple studies now document the role of activated cytotoxic CD8+ T lymphocytes and the interferon gamma–induced chemokine CXCL10 as key immune mediators of melanocyte destruction. Therefore, the interplay between oxidative stress and the immune system may represent critical pathways in vitiligo. Hence, it is a novel and rational strategy to address the role of diet, lifestyle modifications, and oral supplementation with vitamins, minerals, and botanicals as adjunctive approaches in the therapeutically challenging vitiligo arena.




Introduction


Vitiligo is an acquired disorder of pigmentation characterized by well-defined depigmented patches of skin. Biopsies of lesional skin classically reveal an absence of epidermal melanocytes.


Multiple theories have been proffered for melanocyte destruction, including genetic, autoimmune, biochemical, viral, and melanocyte detachment mechanisms. Current research data suggest that autoimmune aberrations and oxidative stress are the key pathways mediating the destruction of melanocytes in vitiligo. Oxidative stress may initiate the cycle of destruction of melanocytes. An altered intracellular redox status and depletion of enzymatic and nonenzymatic antioxidants has been documented in the epidermis of patients with vitiligo. Hence, the generation of reactive oxygen species (ROS) may begin the cycle of destruction of melanocytes in genetically susceptible individuals by activation of the innate and adaptive immune response.


A variety of humoral and cell-mediated immune defects are reported in patients with vitiligo. However, multiple studies now document the role of activated cytotoxic CD8+ T lymphocytes and the interferon gamma–induced chemokine CXCL10 as key immune mediators of melanocyte destruction. Therefore, the interplay between oxidative stress and the immune system may represent critical pathways in vitiligo. Hence, it is a novel and rational strategy to address the role of diet, lifestyle modifications, and oral supplementation with vitamins, minerals, and botanicals as adjunctive approaches in the therapeutically challenging vitiligo arena.




The role of diet in vitiligo management


A review of the literature revealed no controlled studies assessing the role of diet in the prevention or management of patients with vitiligo. However, there are multiple books, web sites, and lay publications recommending unsubstantiated diets and supplements for myriad autoimmune diseases, including vitiligo. In some countries, such as India, patients with vitiligo are cautioned to avoid citrus fruits, sour yogurt, vitamin C products, milk, and fish; however, this is not substantiated in controlled studies (see Vitamin C section).


Although food per se may not appear to play an important role in vitiligo management, there are general dietary recommendations based on the antioxidant, vitamin, and micronutrient composition of foods. For example, vegetable oils that are high in omega-6 may increase the production of ROS and proinflammatory cytokines that may play a role in vitiligo. Dietary choices are also relevant in avoiding foods that could lead to allergic reactions or irritation that could trigger or worsen vitiligo. Celiac disease (CD) is frequently comorbid with myriad other autoimmune diseases, including vitiligo. This disorder is characterized by a general gluten intolerance, whereby gluten ingestion leads to inflammation in the small intestine and malabsorption over time. In a case control study of 64 patients with vitiligo and 64 controls, immunoglobulin (Ig)A anti-endomysial antibodies and IgA antiglutaminase antibodies, which are diagnostic markers for CD, were measured. Two female subjects with vitiligo were found to be seropositive for these antibodies versus none of the controls. The investigators suggest that both CD and vitiligo may be triggered by a common immune system signal associated with a high-gluten diet. Alternatively, both diseases may share similar genetic risks. The author is observing an increasing frequency of CD in her vitiligo patient population at the Vitiligo and Pigmentation Institute of Southern California.


Two case reports in patients with vitiligo who had not responded to topical agents and phototherapy showed some degree of repigmentation with a gluten-free diet. In one patient, who continued on oral dapsone, it was noted that significant repigmentation began within 1 month after initiation of a gluten-free diet. Maximal improvement was achieved by 3 months. In the other study, there was progressive repigmentation over 3 years despite no conventional therapy. Pigmentation was maintained with the gluten-free diet at 7-year follow-up.


A recent study sought to examine the relationship between exposure to a number of thyroid disruptors and toxins and the presence of thyroid hormone antibodies to T3 and T4 in 70 white patients with vitiligo. It was found that 95.7% of the subjects had thyroid hormone antibodies and most had both T3 and T4 antibodies. A significant association was noted between intake of foods containing nitrates (leafy green vegetables), thiocyanate (broccoli, cabbage, and other brassicas), and soy isoflavones and the presence of T3 antibodies.


Oral Supplements


Because many diets do not provide vitamins and minerals in sufficient quantities or types to counter oxidative stress or modulate the immune system, there is increasing interest in supplementation ( Table 1 ). Unfortunately, many patients who seek consultation at the Vitiligo and Pigmentation Institute of Southern California use unreliable sources as a guide for supplementation, ingesting more than 10 agents daily ( Fig. 1 ).



Table 1

Vitamins and supplements for vitiligo
















































Supplement Properties In Vivo Effect on Vitiligo Management
Vitamin B12/folic acid DNA repair, synthesis, methylation of DNA May be used alone or with phototherapy for repigmentation
Vitamin C Antioxidant/immunomodulatory 0.5–2 g per day leads to high antioxidant activity
Vitamin D Melanocyte/keratinocyte growth and differentiation
Inhibits T-cell activation
Increases melanogenesis
Immunomodulatory
High levels of vitamin D may reduce disease activity
Vitamin E Free radical scavenger/inhibits platelet coagulation/antioxidant/anti-inflammatory Alone or with phototherapy leads to rapid repigmentation with photoprotective effects
Decreases oxidative stress and increases effectiveness of phototherapy
Zinc Antioxidant/regulates gene expression/cofactor for superoxide dismutase May offer a slight benefit when combined with topical steroids
Phyllanthus emblica (amla fruit) Antioxidant/anti-inflammatory/antimicrobial/antiviral Decreased phototoxicity from phototherapy and enhances repigmentation
Gingko biloba Antioxidant/anti-inflammatory platelet-activating factor antagonist Slows progression of disease
Polypodium leucotomos Protection, antioxidant, inhibition of apoptosis, immune modulation, decreases proinflammatory cytokines Increased repigmentation in the head and neck areas with phototherapy use
Piperine (animal studies) Stimulates melanocyte replication
Induces formation of melanocytic dendrites
Pigmentation in newly formed melanocytes
Effective when phototherapy is not concurrent to prevent photoisomerization of piperine
Green tea (epigallocatechin-3-gallate) (animal studies) Antioxidant/anti-inflammatory/anti-atherogenic/anticancer Decreases proinflammatory cytokines
Immune modulation



Fig. 1


Vitamins and supplements.


Vitamin B12 and folic acid


Vitamin B12, also known as cobalamin, is a water-soluble vitamin that exerts hematological and neurologic effects. It is 1 of 8 B vitamins. Folic acid (vitamin B9) is the synthetic form of B9 where folate occurs naturally in food.


Humans cannot synthesize folates, hence it must be obtained via diet. Folates are needed for DNA repair, synthesis, and methylation of DNA. They are crucial for cell growth, division, and brain function. Montes and colleagues reported diminished blood levels of vitamin B12, folic acid, and ascorbic acid in a group of 15 patients with vitiligo. Prolonged supplementation with oral folic acid, parental B12, and oral ascorbic acid was associated with repigmentation of vitiliginous patches.


Evidence for vitamin B12 and/or folic acid supplementation, either alone or as an adjuvant to light therapy, is mixed. The rationale for their use is their possible role in melanin synthesis and the possible association of vitiligo and pernicious anemia in which vitamin B12 is insufficiently absorbed. Several groups found no association between serum B12 and folate levels and vitiligo. In one study, 100 patients with vitiligo were treated with 1 mg vitamin B12 and 5 mg folic acid twice daily for 3 months. Patients were also encouraged to expose their skin to sunlight or UVB irradiation. Total repigmentation of sun-exposed skin was achieved in 6 patients. Repigmentation was clearly apparent in 52 patients and was more common in patients younger than 26 years and those with vitiligo of less than 10 years’ duration. Vitiligo progression was halted in 64% of patients. The investigators concluded that B12/folic acid supplementation combined with sun exposure was better in inducing repigmentation than either treatment alone. However, another study showed no advantage to adding B12 and folic acid supplements to narrow-band UVB phototherapy (NB-UVB).


Vitamin C (ascorbic acid)


Vitamin C is a water-soluble vitamin found abundantly in citrus fruits and a variety of leafy vegetables. Multiple studies have documented the beneficial health effects of vitamin C, including its antioxidant and immunomodulatory properties.


It has been suggested that vitamin C supplementation is contraindicated in vitiligo, because of its skin-lightening activity. However, Yoon and colleagues suggested that its antioxidant benefits override this risk. They recommend vitamin C supplementation at a dosage of 0.5 to 2 g per day.


The efficacy and safety of ascorbic acid was assessed in 188 Indian patients with vitiligo. The patients were stratified to 3 groups. Given societal myths regarding ascorbic acid use in vitiligo, 75 avoided vitamin C products. The second group of 113 patients consumed vitamin C daily in their diet and/or medicinal products. A third group of 12 patients ingested vitamin C 1000 mg daily for 6 months. Statistical analysis of the 3 groups showed no difference in the progression of the disease.


Vitamin D


Vitamin D3 binding to vitamin D receptors in the skin affects melanocyte and keratinocyte growth and differentiation and inhibits T-cell activation. Additionally, melanocytes are believed to express 1-alpha-dihydroxyvitamin D3 receptors, which may have a role in stimulating melanogenesis. Moreover, vitamin D is believed to exert immunomodulatory effects by inhibiting the expression of proinflammatory and proapoptotic cytokines. Vitamin D supplementation has been shown to be effective in several animal models of autoimmune diseases. Although it is unknown whether vitamin D deficiency plays a role in human vitiligo, it is reasonable to suggest that vitamin D may be useful as an immunomodulator in this disorder.


Multiple recent studies have addressed vitamin D deficiency in patients with vitiligo. Silverberg and coworkers showed that serum 25(OH) D levels were normal (>30 ng/mL) in 31% of patients, whereas 55.6% were insufficient and 13.3% were very low (<15 ng/mL). Very low levels were associated with comorbid autoimmune diseases. Insufficient levels were associated with increasing Fitzpatrick phototype but not with ethnicity. The investigators suggest that very low 25(OH) D may be a useful screening tool for comorbid autoimmunity in vitiligo. This recommendation was supported by findings of a more recent study that showed lower serum 25 (OH) D levels in patients with vitiligo with autoimmune disease than in those without a comorbid autoimmune disorder. In one study from China, both subjects with vitiligo and controls were found to be universally vitamin D insufficient.


There are a dearth of studies showing the effects of oral vitamin D supplementation in vitiligo. Finamor and colleagues treated 16 patients with 35,000 IU vitamin D3 daily for 6 months in association with a low-calcium diet and adequate hydration for safety. At baseline, 100% of subjects had serum 25 (OH) D3 ≤30 ng/mL. After 6 months of supplementation, levels increased from 18.4 ± 8.9 to 132.5 ± 37.0 ng/mL ( P <.0005). Fourteen of 16 patients with vitiligo achieved 25% to 75% repigmentation. Whenever present, standard treatments were not changed; however, such treatments were not defined. The investigators concluded that this level of supplementation is safe in patients with vitiligo in the setting of calcium restriction and might be effective for reducing disease activity.


Vitamin E


Vitamin E is a fat-soluble vitamin exerting multiple biologic effects, including potent scavenging of free radicals and inhibition of platelet coagulation. Ramadan and coworkers examined levels of vitamin E and paraoxonase (PON1), an important free radical scavenger, in 3 autoimmune disorders, including vitiligo. They found statistically significantly lower tissue and serum levels of both substances in patients with vitiligo compared with controls ( P <.001). Vitamin E supplementation was studied as an adjunct to NB-UVB in 24 patients with stable vitiligo. Patients received either 400 IU vitamin E per day, beginning 2 weeks before the initiation of light therapy or NB-UVB monotherapy. After 6 months of treatment, the combination therapy group showed marked repigmentation in 72.7% versus 55.6% of those receiving NB-UVB monotherapy. Mild erythema was noted in 70% of those receiving combination therapy and 85% receiving light therapy alone, suggesting a UVB-protective effect of vitamin E. The mean number of treatments needed to achieve 50% repigmentation was significantly less with combination therapy. Mean plasma malondialdehyde (MDA), a marker of lipid peroxidation, and reduced glutathione were measured before and after treatment. The combination group showed a significant reduction in plasma MDA compared with the light monotherapy group ( P <.001). There was also a nonsignificant increase in mean serum glutathione in both groups at the end of treatment. The investigators noted that vitamin E may be a useful adjuvant to NB-UVB, preventing lipid peroxidation of melanocyte cell membranes and improving light treatment efficacy.


A small Turkish study of 30 patients who received either 900 IU vitamin E and PUVA or PUVA monotherapy found that the addition of vitamin E to light therapy improved repigmentation. In the combination treatment group, 60% achieved ≥75% repigmentation whereas 20% had 24% to 74% repigmentation. In the PUVA monotherapy group, a combined total of 67% showed these levels of repigmentation.


Vitamin E was also studied as a component of a mixed antioxidant supplement regimen. Dell’Anna and colleagues examined the use of a balanced antioxidant supplement combining vitamins C, E, alpha-lipoic acid, and polyunsaturated fatty acids versus placebo in 35 patients undergoing NB-UVB treatment for vitiligo. Alpha-lipoic acid, also known as lipoic acid, is vital for mitochondrial energy production. It is a powerful antioxidant that stimulates the synthesis of glutathione, a key intracellular antioxidant. Supplementation was administered for 2 months before treatment as well as for the 6 months of light therapy. Area and number of lesions, and redox status of peripheral blood mononuclear cells (PBMCs) were estimated at several time points. After 2 months of the active treatment regimen, catalase activity was 121% of baseline values and the production of ROS was reduced to 57% of baseline ( P <.05 and P <.02 vs placebo). The antioxidant supplement also appeared to improve the efficacy of the NB-UVB in that 47% of the active treatment group achieved greater than 75% repigmentation versus 18% of the placebo group ( P <.05). In PBMCs, there was an increase in catalase activity to 114% of baseline ( P <.05 vs placebo) and a decrease of up to 60% in ROS ( P <.02 vs placebo). The authors concluded that oral supplementation with a mixed antioxidant containing alpha-lipoic acid before and during treatment with NB-UVB enhances the effectiveness of the light therapy and reduced oxidative stress associated with vitiligo.


Zinc


Zinc is an essential mineral that functions as a cofactor for at least 3000 proteins, including enzymes, nuclear factors, and hormones. It regulates gene expression and acts as a cofactor for superoxide dismutase, an antioxidant in the skin. Zinc plays a key role in melanogenesis. Shameer and colleagues assessed zinc levels in 60 patients and found deficiencies in 21.6% of patients with vitiligo compared with controls. In a study by Yaghoobi and colleagues, 35 patients were treated with a topical steroid regimen with and without 440 mg per day of oral zinc supplementation, 16 of whom received no zinc. No difference was noted with zinc levels at baseline. However, at 4 months, there was greater improvement in the group of patients treated with corticosteroids plus zinc. Zinc may offer some benefit when used in combination with other modalities. Gastrointestinal irritation was common.


Herbal Supplements


Other supplements that have been used in the management of vitiligo include a number of botanicals that have been shown to have antioxidant, anti-inflammatory, and immune-modulating properties.


Phyllanthus emblica fruit extract, vitamin E, and carotinoid combination


Phyllanthus emblica , also known as amla fruit or Indian gooseberry, has antioxidant, anti-inflammatory, antimicrobial, and antiviral properties. It contains vitamin C, tannins, and polyphenols.


Colucci and colleagues evaluated the efficacy of an oral supplement containing Phyllanthus emblica fruit extract 100 mg, vitamin E 10 mg, and carotenoids 4.7 mg taken 3 times daily for 6 months. Patients with vitiligo were stratified into 2 groups of 65 patients each. Both groups A and B received the same concomitant topical or phototherapy treatment, whereas only group A received the daily supplement. At 6 months, there was a statistically greater response in group A patients receiving the oral supplement. Compared with group B, greater repigmentation responses were observed on the head, neck, and trunk regions. Group B patients showed statistically significant greater inflammation, erythema, and progression of the disease. Minimal changes were noted in the control group receiving no supplementation.


Ginkgo biloba


Ginkgo biloba (GB) contains bioflavonoids, proanthocyanidens, flavonoids, and trilactonic diterpenes. It exerts multiple antioxidant and anti-inflammatory effects including its antagonizing effects on platelet-activating factor, causing vasodilation. Other mechanisms include its effects on neurotransmission by improving alpha-2-adrenoreceptor activity.


GB extract 40 mg administered 3 times daily for 6 months was shown in a placebo-controlled double-blind study to be effective in arresting the spread of vitiligo in the active treatment group ( P = .006). Ten patients in the GB group achieved marked to complete repigmentation.


A more recent 12-week study showed that 60 mg of standardized GB extract twice per day resulted in improvement in the Vitiligo Area Scoring Index (VASI) and Vitiligo European Task Force (VETF), validated outcome measures of disease area and intensity of depigmentation in 11 of 12 subjects. No other treatments were permitted. VASI scores improved by a mean of 15% with 2 participants showing greater than 30% improvement. VETF scores for total lesion area showed a decrease of 0.36, indicating a 6% decrease in lesion size. The staging scores showed a nonsignificant trend toward improvement in all body areas. GB significantly stopped the spread of vitiligo ( P <.001). Although concern has been raised regarding the effect of GB on coagulation, clotting parameters including serum platelet count, prothrombin, and partial thromboplastin times were similar between baseline and study end.


Polypodium leucotomos


Polypodium leucotomos (PL) is a tropical fern that has been shown to protect against UV radiation–induced damage. Other mechanisms of action of PL include its immunomodulatory effects and inhibition of proinflammatory cytokines. In 1989, Mohammad ushered PL into the realm of dermatology. Anapsos is a lipid-soluble derivative of PL. Mohammad treated 22 patients with Anapsos, and 100% repigmented. The study was conducted in the summer months so the patients were also exposed to daily sunlight.


In a randomized, double-blind, placebo-controlled pilot study, PL + PUVA treatment produced significantly more patients who achieved greater than 50% repigmentation compared with PUVA + placebo ( P <.01). Repigmentation was inversely correlated with decreases in CD3+CD25 + T cells.


In another study, 50 patients undergoing NB-UVB twice weekly were randomized to receive either PL 250 mg or placebo 3 times per day for 25 to 26 weeks. Repigmentation in the head and neck area was higher in the active treatment group than in the placebo group ( P = .06). Subjects in the PL group who attended more than 80% of the required phototherapy sessions showed more repigmentation in the head and neck than those in the placebo group (50% vs 19%, P <.002).


Piperine


Piperine, the major alkaloid of black pepper, has been shown to stimulate the replication of melanocytes and induce formation of melanocytic dendrites in vitro. Piperine has therefore been suggested as a possible treatment for vitiligo in the setting of UV exposure to induce pigmentation in newly formed melanocytes. Soumyanath and colleagues assessed the effects of UV irradiation on melanocytes stimulated by piperine. In a mouse cell line (called melan-a), piperine stimulated melanocyte proliferation and dendrite formation only when not in combination with UVA. The investigators noted that the UV-induced photoisomerization of the piperine molecule resulted in the loss of protein binding and melanocyte stimulatory activity. In their study of hairless pigmented mice, animals were treated with dimethyl sulfoxide (DMSO) solution or piperine dissolved in DMSO solution for 9 weeks, piperine and DMSO plus simulated solar UVA 3 times per week just before piperine application from weeks 5 to 9, or UVA only for 5 weeks. The melanocyte stimulatory effect of piperine was retained and pigmentation was greater in mice treated with both piperine and ultraviolet radiation (UVR) than with either as monotherapy. The investigators note than when UVR and piperine are used to treat vitiligo, they should be used at different times to avoid photoisomerization of piperine.


Another animal study tested twice-daily application of piperine or 1 of 3 of its analogs or vehicle without or without UVR for 3 days per week. After 4 weeks of treatment, all but one of the analogs produced greater levels of pigmentation than vehicle with low levels of inflammation. The addition of UVR produced darker pigmentation than either treatment alone. The pigmentation achieved with combination therapy was more even than the speckled perifollicular pattern achieved with UVR alone. When treatment was discontinued, pigmentation decreased but did not disappear and could be restarted with piperine analogs or UVR or the combination.


Green tea epigaollocalechin-3-galate


Multiple studies now document the beneficial effects of green tea (GT). Catechins contained in GT are responsible for its myriad biological effects. GT catechins include epigallocatechin, epicatechin, epicatechin-3-gallate, and epigallocatechin-3-gallate (EGCG). EGCG is the most abundant and biologically active compound in GT. EGCG has antioxidant, anti-inflammatory, anti-atherogenic, and anticancer properties. EGCG modulates multiple T-cell–mediated immune responses. Zhu and colleagues assessed the therapeutic effects of EGCG in vitiligo induced by monobenzone in mice. EGCG delayed the time of onset, prevalence, and surface area of monobenzone-induced depigmentation on use. Moreover, treatment with EGCG significantly decreased the production of proinflammatory cytokines, including tumor necrosis factor-α, interferon γ, and interleukin-6. These findings suggest that antioxidant and immunomodulatory effects of GT should be further assessed in clinical trials.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 11, 2018 | Posted by in Dermatology | Comments Off on The Role of Diet and Supplements in Vitiligo Management

Full access? Get Clinical Tree

Get Clinical Tree app for offline access